Inflammation and wound healing: a comprehensive overview of mechanisms, therapeutic strategies, and translational perspectives Authors: Yixiao Zhang, Dezhi Guo, Lizhou Song, Guowei Su, Zhiheng Lin, Haoling Zhang, Haifang Wan, Wangzheqi Zhang, Zui Zou Published: 2026 ABSTRACT Wound healing is the dynamic biological process by which an organism restores homeostasis following injury and is characterized by a series of stages resulting in hemostasis, inflammatory response, proliferation, and tissue remodeling. As a consequence, the inflammatory response represents a key early step in this process and plays a central role in clearing necrotic debris and pathogens, as well as inducing reparative pathways. Mild to moderate inflammation induces angiogenesis, fibroblast activation, and extracellular matrix (ECM) remodeling, whereas chronic or excessive inflammation causes tissue damage, fibrosis, and chronic non-healing wounds. The current review systematically illustrates the contribution and dynamics of the inflammatory response underlying wound healing. These processes consist of immune cell polarization, regulation of cytokines and chemokines, and signaling network dynamics, hence emphasis is laid on the canonical mechanism for maintaining steady-state tissue restoration, namely, immune homeostasis. Moreover, this review examines the dynamic cross-talk of growth factors, ECM components, and angiogenesis in different healing phases. An overview of novel interventions is also included such as negative pressure wound therapy (NPWT), hyperbaric oxygen, exosome-based approaches, biomaterial-based approaches, nanohydrogel systems, and microneedle-facilitated delivery, with insights into mechanisms and translational progress. Critical clinical translation barriers, including wound heterogeneity, host-microbe cross-talk, and limitations of model extrapolation as well as the potential application of multi-omics integration and an interdisciplinary approach towards precision wound healing, are discussed. Overall, regulation of inflammation is the foundation for the whole wound healing cascade, and immune homeostasis is a key prerequisite for injury repair. Tailored therapeutic strategies might thus greatly enhance healing outcomes and clinical efficacy.Graphical Abstract Introduction The healing of wounds is an extremely complicated biological process during which the body rebuilds tissue structure and function to normalcy after sustaining injury. It includes a series of overlapping and highly regulated stages: hemostasis, inflammation, proliferation, and remodeling [1]. During early phases, the inflammatory response is important for clearing necrotic tissue and pathogens but also provides a foundation for later repair and regeneration. However, when the inflammatory response becomes excessive or fails to resolve in a timely manner, it may impair wound healing and contribute to chronic wound formation, representing an important pathological basis of refractory wounds in clinical practice [2, 3]. Recent progress in molecular biology, immunology, and regenerative medicine has deepened our understanding of the dual functions and intricate regulatory pathways of inflammation during wound healing. Accumulating experimental evidence demonstrates that moderate inflammation is required for angiogenesis, fibroblast activation and ECM deposition, which are prerequisites for effective tissue repair in the clinical setting [4]. However, an excessive or prolonged inflammatory response will disturb the local micro-environment [5], which will retard and interfere with reparative cell activity; when combined with factors such as infection, diabetes and immune dysregulation [6], it will greatly increase the risk for chronic wound development. Therefore, precisely regulating the inflammatory response to both preserve host defense and promote tissue regeneration has become a central issue in wound healing research and clinical intervention. Traditional anti-inflammatory medications to the latest interventional techniques such as biomaterials, gene regulation, and precision medicine have all shown promise in correcting the imbalance and promoting healing. Novel technologies such as single-cell sequencing and spatial transcriptomics provide a 4D view to reveal the dynamic mechanisms of inflammation and wound healing that would facilitate the translation of basic study findings into clinical practice [7, 8]. However, wound heterogeneity, host–microbe interactions, and the limitations of extrapolating across models remain major challenges for clinical translation in this field. To that end, a systematic review addressing the mechanistic roles of inflammation in wound healing, summarizing current and promising therapies along with opportunities and challenges in translating findings from bench to bedside is clinically valuable for promoting precision therapy and improving wound care. This review provides an overview of the relationship between inflammation and wound healing and discusses regulatory mechanisms as well as potential therapeutic strategies for recalcitrant wounds and translational prospects, providing a theoretical reference for future basic research and clinical practice. Basic mechanisms of inflammation Detailed analysis of the biological differences between acute and chronic inflammation The roles of acute and chronic inflammation in immune response are different and show clear biological disparities. Acute inflammation is generally an early and rapid reaction of the body to exogenous infection, injury or pathological stimulation for rapid eradication of pathogens, restoration of injured tissue and restoration of function [9]. Acute inflammatory responses have the features of a rapid onset and short duration; generally, they resolve after a few hours to days once the offending agent has been cleared or tissue repair is completed. During the initial phase of acute inflammation, leucocytes are rapidly recruited to the site of injury or infection and contribute to pathogen clearance as well as the maintenance of tissue homeostasis [10]. On the other hand, chronic inflammation is defined as a sustained immune response usually in association with infections unresolvable by acute inflammation, prolonged irritations or dysfunction of the immune system [11]. Chronic inflammation is characterized by prolonged infiltration of immune cells, sustained release of cytokines, and fibrotic processes, all of which collectively drive the onset and progression of chronic diseases [12]. Such distinctions between acute signs of inflammation and chronic inflammation are likewise reflected in their biomarkers. Acute inflammation is usually associated with an increase in acute-phase proteins such as C-reactive protein (CRP). Moreover, pro-inflammatory cytokines such as TNF-α and IL-1 are promptly released, which helps to activate the immune response early against these external agents for their elimination [13]. Acute inflammation is resolved through the elimination of neutrophils; however, if this immune response is not properly managed, chronic inflammation may occur. Additionally, citrullination has been implicated in the regulation of acute inflammation, particularly through modulation of protein function and immune signaling pathways [14]. The pathophysiological distinctions between the two inflammatory types are mainly manifested based on the temporal response, the specific cell population, the altered production of cytokines, and their consequential effects on the body. Acute inflammation aims to rapidly resolve infection or injury [15], whereas chronic inflammation may lead to persistent disease progression and tissue damage [16]. Importantly, these two forms of inflammation are not isolated states but represent a continuum regulated by the balance between immune activation and resolution pathways. Dysregulation of this balance, rather than the presence of inflammation itself, is a key determinant of pathological outcomes in wound healing [17]. Exploration of the roles of immune cells in the inflammatory response The participation of immune cells, primarily macrophages, neutrophils, and lymphocytes, is particularly important in the inflammatory phase of wound healing [18, 19]. Complex signaling pathways and intercellular interactions between these immune cells orchestrate inflammatory initiation, amplification, and resolution. Macrophage contribution to inflammatory polarization is regulated, at least in part, by Notch signaling and its association with NF-κB-related pathways, influencing pro-inflammatory activation and the progression and resolution of inflammation, with implications for tissue repair and wound healing [20]. The knockout of nuclear factor erythroid 2-related factor 2 (Nrf2) facilitates differentiation toward the M1 phenotype and suppresses autophagic activity, thereby promoting a pro-inflammatory state. During neutrophil-associated cell death processes, macrophages also regulate ROS signaling. Tim-3 knockdown in macrophages induces the production of tumor-associated neutrophils (TANs) and enhances neutrophil-mediated inflammatory responses, thereby amplifying inflammatory signaling. Macrophages also contribute to inflammatory responses under polystyrene microplastics (PS-MPs) exposure via ROS overproduction and subsequent activation of autophagy pathways, ultimately promoting the formation of macrophage extracellular traps (METs) [21]. Dysregulation of macrophage autophagy is associated with altered inflammatory responses, particularly through modulation of macrophage polarization, suggesting that macrophage autophagy may play a context-dependent role in regulating inflammation and tissue repair [22]. Targeting macrophage autophagy is therefore worthy of consideration [23]. In addition, macrophage-provided SO₂ controls the activation of NF-κB signaling through AAT2 as a crucial switch [24]. Neutrophils regulate immune responses through interactions with T cell subsets and microbiota-derived metabolites, thereby modulating inflammatory signaling. Immune cells participate in the inflammatory response through complex and coordinated mechanisms, in which macrophages represent key regulators across different types of inflammation [25]. Ranging from macrophage polarization to neutrophil, T cell, and B cell interactions, these immune cells not only mediate inflammatory responses in pathogenesis but also contribute to tissue repair through cytokine release and immunomodulation. However, hyperactive immune responses manifest as chronic inflammation and tissue injury, both of which are major barriers to wound repair. Together, these insights reveal that immune cell function during inflammation is controlled by integrated signaling networks rather than singular pathways, with macrophage polarization and intercellular communication representing focal nodes connecting inflammatory responses to tissue repair outcomes [26, 27]. In addition to signaling regulation, metabolic reprogramming represents a fundamental layer of immune cell control during wound healing. Pro-inflammatory immune cells, particularly M1-like macrophages, are often associated with glycolytic metabolism to sustain rapid ATP production, ROS generation, and cytokine release during early inflammation [28]. In contrast, the transition toward resolution and tissue repair is accompanied by a metabolic shift toward oxidative phosphorylation and fatty acid oxidation, which supports M2-like macrophage polarization, efferocytosis, and ECM deposition. Consistently, signaling pathways such as TGF-β/SMAD have been shown to promote M2 macrophage polarization and ECM production, thereby accelerating wound healing in diabetic ulcers [29]. Failure of this transition is associated with persistent inflammation in chronic wounds. Therefore, metabolic reprogramming is not merely a consequence of immune activation but a key determinant of whether inflammation resolves or progresses toward pathological states. Importantly, while the diverse components of inflammatory pathways are summarized in Table 1, these elements are not independent from one another and can broadly be categorized into coordinated regulatory patterns including (i) pro-inflammatory activation, (ii) immune modulation and metabolic adaptation, and (iii) resolution-associated responses. This indicates that inflammation relevant to wound healing is a functionally integrated process rather than isolated events [30]. Collectively, these findings highlight that immune cell-mediated inflammatory regulation is closely linked to tissue repair outcomes. The table summarizes the main immune cell differentiation, key signaling pathways, and disease-associated phenotypes across multiple inflammatory contexts, including different types of wound models and experimental settings. Although these models are not entirely equivalent across tissue-specific wound healing contexts, they are included to illustrate conserved regulatory mechanisms that are broadly relevant to inflammation-associated tissue repair. Table 1Roles of immune cells in cutaneous and tissue wound healing: evidence from experimental wound-healing modelsImmune cell typeFunctional role in wound healingKey signaling pathwaysMajor secreted factorsEffects on wound healingWound model typeReferencesMacrophagesPromotes M2 polarization and suppresses pro-inflammatory cytokinesNF-κB signaling inhibition; macrophage polarizationPro-inflammatory cytokines (suppressed)Attenuates inflammation, promotes transition from inflammatory to proliferative phase, accelerates chronic wound healingDiabetic cutaneous wound model (streptozotocin-induced rat and db/db mouse) [31] MacrophagesPromotes M1-to-M2 reprogramming and immune regulationNF-κB signaling; inflammation-related pathwaysTNF-α, IL-10, inducible nitric oxide synthase (iNOS), Arg-1, vascular endothelial growth factor A (VEGFA)Reduces inflammatory infiltration, promotes angiogenesis and collagen deposition, accelerates wound closure and tissue repairDiabetic full-thickness cutaneous wound model (streptozotocin-induced rat) [32] MacrophagesPromotes M2 polarization and tissue repairIL-4/JAK1/STAT6 signaling; RAS-mediated endocytosis; PAK pathwayArg-1, Mrc1, Retnla, TNF-αEnhances wound closure, angiogenesis, and tissue remodeling; GLUT3 deficiency delays healingExcisional cutaneous wound model (mouse) [33] MacrophagesRegulates inflammatory response and scar formation by controlling early macrophage recruitmentIntegrin αL-mediated monocyte migration and extravasationTNF-α, IL-10, TGF-β1Reduces macrophage infiltration, attenuates early inflammation, decreases profibrotic signaling, and improves scar qualityPartial-thickness scald burn wound model (mouse) [34] NeutrophilsExcess neutrophil extracellular traps (NETs) formation impairs wound repair and angiogenesisToll-like receptor 9 (TLR9)-PAK2-Merlin/NF2-Hippo-YAP-SMAD2 signaling axisNET components (DNA, histones, myeloperoxidase, neutrophil elastase)Induces endothelial-to-mesenchymal transition (EndMT), inhibits angiogenesis, and delays wound healing; NETosis inhibition accelerates wound closure and improves perfusionDiabetic full-thickness cutaneous wound model (streptozotocin-induced mouse) [35] NeutrophilsNETs scavenging alleviates excessive inflammationNETs-cfDNA scavenging; TLR9-related signaling; ROS modulationInflammatory cytokines (reduced)Reduces NETs accumulation and inflammation, promotes macrophage M2 polarization, and accelerates wound healing (including enhanced re-epithelialization, angiogenesis, and collagen deposition)Diabetic full-thickness cutaneous wound model (streptozotocin-induced mouse) [36] Neutrophils and macrophagesNeutrophil-derived exosomes regulate immune microenvironment and promote macrophage polarizationVEGF delivery-mediated angiogenic signaling; ECM-mediated immunomodulationVEGFPromotes angiogenesis, collagen deposition, re-epithelialization, and wound closure; enhances macrophage M2 polarization and reduces inflammationDiabetic full-thickness cutaneous wound model (streptozotocin-induced rat) [37] Dendritic cellsSLC7A11 inhibition enhances efferocytosis in dendritic cellsSLC7A11-mediated regulation of efferocytosis and glucose metabolismGDF15Promotes apoptotic cell clearance and accelerates wound healingExcisional cutaneous wound model (mouse) and diabetic wound model (db/db mouse) [38] Dendritic cellsNdrg2 knockout preserves an immature dendritic cell state with pro-angiogenic and regenerative capacityNdrg2 knockout; VEGF, PDGF, insulin-like growth factor (IGF), and SPP1 signalingVEGFAAccelerates wound healing, promotes re-epithelialization, and enhances vascularizationFull-thickness excisional wound model (wild-type and db/db mice) [39] Dendritic cellsRegulates dendritic cell-mediated inflammatory response in diabetic corneal wound healingNerve growth factor (NGF)/Tropomyosin receptor kinase A (TrkA)-mediated inhibition of NF-κB signalingIL-6, TNF-αReduces inflammation, promotes corneal epithelial wound healing, and enhances nerve regenerationDiabetic corneal epithelial wound model (streptozotocin-induced mouse) [40] Epidermal γδ T cellsRegulate early wound repair through cytokine productionCCR6-CCL20-IL-17 axisIL-17 APromotes wound repair, whereas CCR6 deficiency delays wound closureCutaneous wound model (2 mm punch biopsy, mouse) [41] Vγ4 γδ T cellsPromote wound healing through cytokine-mediated immune regulationCCL20-Vγ4 T cell-IL-22 axisIL-22Enhances wound healing, whereas reduced Vγ4 T cell recruitment or IL-22 inhibition delays wound closureFull-thickness cutaneous wound model (mouse) [42] Regulatory T cellsPromote corneal wound healing by suppressing excessive inflammation and enhancing epithelial regenerationAreg-dependent reparative mechanism; suppression of inflammatory signalingAreg, IL-10, TGF-βAccelerates re-epithelialization, alleviates corneal edema and opacity, and reduces fibrosis and neovascularizationCorneal alkali burn wound model (mouse) [43] Table 1Roles of immune cells in cutaneous and tissue wound healing: evidence from experimental wound-healing modelsImmune cell typeFunctional role in wound healingKey signaling pathwaysMajor secreted factorsEffects on wound healingWound model typeReferencesMacrophagesPromotes M2 polarization and suppresses pro-inflammatory cytokinesNF-κB signaling inhibition; macrophage polarizationPro-inflammatory cytokines (suppressed)Attenuates inflammation, promotes transition from inflammatory to proliferative phase, accelerates chronic wound healingDiabetic cutaneous wound model (streptozotocin-induced rat and db/db mouse) [31] MacrophagesPromotes M1-to-M2 reprogramming and immune regulationNF-κB signaling; inflammation-related pathwaysTNF-α, IL-10, inducible nitric oxide synthase (iNOS), Arg-1, vascular endothelial growth factor A (VEGFA)Reduces inflammatory infiltration, promotes angiogenesis and collagen deposition, accelerates wound closure and tissue repairDiabetic full-thickness cutaneous wound model (streptozotocin-induced rat) [32] MacrophagesPromotes M2 polarization and tissue repairIL-4/JAK1/STAT6 signaling; RAS-mediated endocytosis; PAK pathwayArg-1, Mrc1, Retnla, TNF-αEnhances wound closure, angiogenesis, and tissue remodeling; GLUT3 deficiency delays healingExcisional cutaneous wound model (mouse) [33] MacrophagesRegulates inflammatory response and scar formation by controlling early macrophage recruitmentIntegrin αL-mediated monocyte migration and extravasationTNF-α, IL-10, TGF-β1Reduces macrophage infiltration, attenuates early inflammation, decreases profibrotic signaling, and improves scar qualityPartial-thickness scald burn wound model (mouse) [34] NeutrophilsExcess neutrophil extracellular traps (NETs) formation impairs wound repair and angiogenesisToll-like receptor 9 (TLR9)-PAK2-Merlin/NF2-Hippo-YAP-SMAD2 signaling axisNET components (DNA, histones, myeloperoxidase, neutrophil elastase)Induces endothelial-to-mesenchymal transition (EndMT), inhibits angiogenesis, and delays wound healing; NETosis inhibition accelerates wound closure and improves perfusionDiabetic full-thickness cutaneous wound model (streptozotocin-induced mouse) [35] NeutrophilsNETs scavenging alleviates excessive inflammationNETs-cfDNA scavenging; TLR9-related signaling; ROS modulationInflammatory cytokines (reduced)Reduces NETs accumulation and inflammation, promotes macrophage M2 polarization, and accelerates wound healing (including enhanced re-epithelialization, angiogenesis, and collagen deposition)Diabetic full-thickness cutaneous wound model (streptozotocin-induced mouse) [36] Neutrophils and macrophagesNeutrophil-derived exosomes regulate immune microenvironment and promote macrophage polarizationVEGF delivery-mediated angiogenic signaling; ECM-mediated immunomodulationVEGFPromotes angiogenesis, collagen deposition, re-epithelialization, and wound closure; enhances macrophage M2 polarization and reduces inflammationDiabetic full-thickness cutaneous wound model (streptozotocin-induced rat) [37] Dendritic cellsSLC7A11 inhibition enhances efferocytosis in dendritic cellsSLC7A11-mediated regulation of efferocytosis and glucose metabolismGDF15Promotes apoptotic cell clearance and accelerates wound healingExcisional cutaneous wound model (mouse) and diabetic wound model (db/db mouse) [38] Dendritic cellsNdrg2 knockout preserves an immature dendritic cell state with pro-angiogenic and regenerative capacityNdrg2 knockout; VEGF, PDGF, insulin-like growth factor (IGF), and SPP1 signalingVEGFAAccelerates wound healing, promotes re-epithelialization, and enhances vascularizationFull-thickness excisional wound model (wild-type and db/db mice) [39] Dendritic cellsRegulates dendritic cell-mediated inflammatory response in diabetic corneal wound healingNerve growth factor (NGF)/Tropomyosin receptor kinase A (TrkA)-mediated inhibition of NF-κB signalingIL-6, TNF-αReduces inflammation, promotes corneal epithelial wound healing, and enhances nerve regenerationDiabetic corneal epithelial wound model (streptozotocin-induced mouse) [40] Epidermal γδ T cellsRegulate early wound repair through cytokine productionCCR6-CCL20-IL-17 axisIL-17 APromotes wound repair, whereas CCR6 deficiency delays wound closureCutaneous wound model (2 mm punch biopsy, mouse) [41] Vγ4 γδ T cellsPromote wound healing through cytokine-mediated immune regulationCCL20-Vγ4 T cell-IL-22 axisIL-22Enhances wound healing, whereas reduced Vγ4 T cell recruitment or IL-22 inhibition delays wound closureFull-thickness cutaneous wound model (mouse) [42] Regulatory T cellsPromote corneal wound healing by suppressing excessive inflammation and enhancing epithelial regenerationAreg-dependent reparative mechanism; suppression of inflammatory signalingAreg, IL-10, TGF-βAccelerates re-epithelialization, alleviates corneal edema and opacity, and reduces fibrosis and neovascularizationCorneal alkali burn wound model (mouse) [43] Roles of immune cells in cutaneous and tissue wound healing: evidence from experimental wound-healing models Regulatory mechanisms of cytokines and chemokines in the inflammatory response The inflammatory response is a biological process that occurs in the body in reaction to tissue injury, infection, or other forms of tissue damage and is an important temporary protective mechanism aimed at preserving tissue integrity and restoring function through coordinated cellular and molecular mechanisms [44]. Inflammation can be categorized as acute and chronic. Acute inflammation is generally the early response to injury, which entails vascular responses, leukocyte accumulation, and cytokine production, leading to a localized inflammatory microenvironment [45, 46]. In this process, cytokines and chemokines act as key regulatory factors, modulating immune cell activation, migration, and the persistence of the inflammatory response, thereby facilitating repair and regeneration at the site of injury. Cytokines, especially pro-inflammatory cytokines, play a crucial role in the inflammatory response. Recombinant human IL-37 suppresses the production of Th2 cytokines in allergen-activated mononuclear cells (MNCs) from wild-type mice and inhibits IL-33-induced Th2 cytokine release [47]. Furthermore, the IL-17 signalling pathway also aggravates the muscle inflammatory response by activating neutrophils and inducing the production of pro-inflammatory mediators such as IL-1β, IL-6, and TNF-α [48]. IL-15 significantly alleviates inflammation in collagen-induced arthritis models through its receptor complex, IL-15Rα/IL-2Rβ/γc [49]. Meanwhile, IL-38 mitigates myocardial ischemia–reperfusion injury (MIRI) by suppressing macrophage-mediated inflammatory responses, thereby reducing both the expression of inflammatory cytokines and cardiomyocyte apoptosis [50]. Chemokines are key bridging molecules for immune responses, as they encode information that directs circulating immune cells to the place of injury or infection. For example, macrophage migration inhibitory factor (MIF) has a critical role in renal post-injury inflammation, immune cell recruitment, and ECM deposition, and demonstrates specific therapeutic potential for fibrotic kidney diseases [51]. IL-17 A blockade ameliorates inflammatory and fibrotic responses by blocking the CXCL5/CXCR2 pathway [52]. An overview of the dynamic variations and molecular mechanisms that instruct the inflammatory process during wound healing is illustrated through a stage-specific diagram of inflammatory signaling pathways in Fig. 1, whereby the progression from immune recognition to resolution and repair is integrated across various immune cell types at different time points. Cytokines and chemokines regulate the initiation, maintenance, and resolution of inflammation through intricate signaling networks, thus facilitating wound healing and being critical for the balance between tissue repair and fibrosis [53]. These processes ultimately converge on the maintenance or disruption of immune homeostasis, which determines the success or failure of wound healing. Fig. 1Stage-specific inflammatory response and cytokine-mediated regulatory mechanisms in wound healing. This schematic summarizes the regulation of stage-specific inflammation corresponding to initiation, amplification, and resolution during wound healing at both the molecular and cytokine levels. In the initiation phase, various injury-induced signals, including DAMPs and PAMPs, stimulate immune recognition, vascular dilation, leukocyte recruitment, and cytokine production. In the amplification phase, mediated by cytokines (including IL-17), neutrophils are activated and a series of proinflammatory mediators such as IL-1β, IL-6, and TNF-α are released. Various regulatory cytokines such as IL-33, IL-37, IL-15, and IL-38 are implicated in the regulation of inflammatory responses under various pathological conditions. Inflammation resolution, tissue repair, and homeostasis restoration are mediated in the resolution phase via anti-inflammatory mechanisms such as IL-17 A/CXCL5/CXCR2 signaling and exogenous IL-27. Dysregulation of these processes can result in chronic inflammation and profibrotic features marked by the accumulation of extracellular matrix components Stage-specific inflammatory response and cytokine-mediated regulatory mechanisms in wound healing. This schematic summarizes the regulation of stage-specific inflammation corresponding to initiation, amplification, and resolution during wound healing at both the molecular and cytokine levels. In the initiation phase, various injury-induced signals, including DAMPs and PAMPs, stimulate immune recognition, vascular dilation, leukocyte recruitment, and cytokine production. In the amplification phase, mediated by cytokines (including IL-17), neutrophils are activated and a series of proinflammatory mediators such as IL-1β, IL-6, and TNF-α are released. Various regulatory cytokines such as IL-33, IL-37, IL-15, and IL-38 are implicated in the regulation of inflammatory responses under various pathological conditions. Inflammation resolution, tissue repair, and homeostasis restoration are mediated in the resolution phase via anti-inflammatory mechanisms such as IL-17 A/CXCL5/CXCR2 signaling and exogenous IL-27. Dysregulation of these processes can result in chronic inflammation and profibrotic features marked by the accumulation of extracellular matrix components Biological process of wound healing Analysis of the different stages of wound healing: hemostasis, inflammation, proliferation, and remodeling Healing is a complex, multi-component biological process that can be divided into four sequential and overlapping phases, including hemostasis, inflammation, proliferation, and remodeling. All these phases are essential for tissue repair and closely depend on each other. In a process referred to as hemostasis, platelets adhere and aggregate rapidly at the wound site, then degranulate to release a wide range of bioactive molecules that can activate the coagulation cascade, which can both help prevent blood loss and serve to stabilize the environment around the injured tissue [54, 55]. Following this, during the induction of inflammation, immune cells including macrophages are rapidly recruited to damaged sites to scavenge dead cells and eliminate potential pathogens while also secreting cytokines in favor of tissue repair. In addition to canonical immune signaling, neuro-immune crosstalk is an important early regulator of wound healing [56]. Following tissue injury, sensory nerve endings rapidly detect noxious stimuli and release neuropeptides such as substance P and calcitonin gene-related peptide (CGRP), which modulate local vascular tone, leukocyte recruitment, and cytokine production. These signals influence the activation state of resident macrophages, neutrophils, mast cells, and keratinocytes, thereby helping to initiate the repair cascade [27]. In contrast, inflammatory mediators released by immune cells can further modulate neuronal excitability and neuropeptide output, creating a bidirectional regulatory loop. Alterations to this neuro-immune cross-talk may impair the timing of inflammatory activation, re-epithelialization, and subsequent tissue remodeling. In this phase, the interaction of pro-inflammatory macrophages with fibroblasts leads to keratinocyte migration and subsequent wound healing [57]. The proliferation stage is the main phase of wound healing. During this phase, fibroblasts proliferate extensively in response to growth factors and synthesize ECM components such as collagen, which acts as a scaffold for new tissue formation [58]. Angiogenesis, meanwhile, provides the wound with appropriate blood supply to deliver oxygen and nutrients for healing. Research shows that in capsaicin-treated wounds, the density of angiogenesis and collagen deposition at the end stage of healing is significantly higher compared with control, suggesting CAP can effectively promote wound healing by suppressing the inflammatory response and advancing its healing stages [59]. Moreover, during proliferation stage, the expression of proinflammatory mediators such as TNF-α, IL-6 and matrix metallopeptidase (MMP)-9 is temporally changing so that it accurately controls both degree and length of inflammation in wound healing process [60]. Remodeling is the fourth and last phase of wound healing. Throughout this phase fibroblast activity decreases and the collagen fibers are remodeled, increasing the strength of the healed tissue and returning its structure towards that of normal, uninjured tissue. It has been found that Th17 cells induce inflammatory responses and fibrogenic process during the development of hypertrophic scarring (HS) through an IL-17–mediated signal pathway [61]. Additionally, it has been shown that exosomes derived from adipose-derived stem cells (ASCs) enhance the wound healing process by stimulating fibroblast proliferation, migration, and collagen production [62]. There are, however, several causes of delayed wound healing. Specifically, in mouse models of diabetes, retarded apoptosis results in a marked delay in healing. In addition, chronic infection-induced inflammation can significantly prolong the process of wound healing, leading to a delay in complete closure [63, 64]. Therefore, the accurate control of biological events at each phase during wound healing process is essential for perfect tissue repair and functional recovery. In addition, plasma coagulation factors such as thrombin, as well as platelet-associated coagulation processes, not only initiate clot formation but also serve as important signaling mediators that regulate inflammation and immune cell recruitment [65]. These processes ultimately converge on the maintenance of immune homeostasis, which is essential for coordinated progression through the stages of wound healing [66]. To provide an integrated perspective for a better understanding of cellular composition and molecular regulatory characteristics at different time points of hemostasis, inflammation, proliferation, and remodeling during wound healing stages, a summary overview of key cells in wound healing, including core signaling molecules and pathways as well as functions, is compiled time point-wise, as summarized in Table 2. This compilation highlights the dynamic temporal sequence and molecular network characteristics of wound healing, which provides a systematic basis to deepen our knowledge of the mechanisms behind tissue repair. Table 2Biological processes of wound healing and their key molecules and cell typesBiological ProcessMajor Cell TypesKey MoleculesSignaling PathwaysBiological FunctionTemporal PhaseReferencesImmunothrombosisEndothelial Cells, PlateletsHistones, VWFCalcium/Caspase PathwaysPromotes Platelet Adhesion and AggregationEarly/Acute Phase [67] Blood CoagulationPlatelets, LeukocytesEnzymatically Oxidized PhospholipidsLipoxygenase PathwaySeals Wound, Prevents InfectionHemostasis Phase [68] ECM Synthesis and DepositionHuman Dermal FibroblastsTGF-β1, pSmad2/3TGF-β1/Smad PathwayPromotes Collagen Synthesis and Cell ProliferationEarly Repair Phase [69] Early Angiogenesis and Late Anti-FibrosisEndothelial Cells, FibroblastsVEGF, TGF-βVEGF, TGF-βPromotes Healing, Prevents Scar FormationEarly and Late Phases [70] Myofibroblast Apoptosis and Scar ResolutionMyofibroblastsFibromodulin, IL-1βIL-1β Signaling PathwayInduces Apoptosis to Reduce Scar FormationPost-Wound Closure [71] Fibrosis and Regenerative HealingMyofibroblasts, MacrophagesTGF-β1, BCL-2TGF-β1 PathwayRegulates Inflammation and Fibrosis7 Days Post-Injury [72] Skin Wound HealingEndothelial Progenitor CellsSDF-1, CXCR4SDF-1/CXCR4 PathwayPromotes Wound RepairRepair Phase [73] Macrophage PolarizationMacrophagesLipin-1IL-4/STAT6/PPARγ PathwayPromotes Healing Phenotype TransitionLate Inflammatory Phase [74] Skin Wound HealingKeratinocytesFocal adhesion kinase (FAK)FAK Signaling PathwayPromotes Proliferation and DifferentiationRepair Phase [75] Chronic Wound HealingMacrophagesCytokines, Growth FactorsExtracellular Signal-Regulated Kinase (ERK) PathwayPromotes Angiogenesis, Anti-InflammatoryChronic/Repair Phase [76] Epidermal Wound HealingEpidermal CellsVacuolar H+-ATPaseERK Signaling PathwayActivates Repair GenesRepair Phase [77] Skin Inflammation/Wound HealingKeratinocytes, FibroblastsCannabidiol, NF-κBNF-κB Signaling PathwaySuppresses Inflammatory ResponseInflammatory Phase [78] Granulation tissue formation and cell proliferationDermal fibroblastsIGF-I, IGFBP-1IGF-I/ERK pathwayPromotes cell proliferation and tissue repairProliferative phase [79] Granulation tissue formation and wound contractionFibroblasts and myofibroblastsTGF-β, type I/III collagenTGF-β signaling pathwayPromotes tissue formation and contractionEarly proliferative phase [80] Inhibition of fibrosis and promotion of epithelializationKeratinocytes and fibroblastsFGF7, Fibroblast growth factor receptor 1 (FGFR1), FGFR2FGF/FGFR signaling pathwayInhibits scar formationProliferative/reconstruction phase [81] Angiogenesis and inflammatory responseEpithelial cells and endothelial cellsS100A12, KLF5, receptor for advanced glycation end products(RAGE)/Toll-like receptor 4 (TLR4)RAGE/TLR4 signaling pathwayImpairs endothelial function and delays wound healingInflammatory/proliferative phase [82] Endothelial cell migration and fibroblast activationEndothelial cells and fibroblastsSRY (sex-determining region Y)-box transcription factor 17 (SOX17), DNA methyltransferase 3 alpha (DNMT3α), TGF-βDNMT3α/SOX17/TGF-β pathwayPromotes cell migration and activationProliferative phase [83] Cell migration and proliferationKeratinocytes and fibroblastsAMP-IBP5, LRP1MAPK signaling pathwayPromotes cell migration and proliferationProliferative phase [84] Wound healing and tissue regenerationB cells, CD4+ T cells, and CD8+T cellsmiR-223-3p, miR-142a-5p, miR-144-3pErbB, FoxO, Hippo, and PI3K-Akt signaling pathwaysRegulates gene expression and promotes healingInflammatory phase [85] Note: This table summarizes key cellular and molecular events primarily in wound healing, with selected evidence from related tissue injury models where appropriate to illustrate conserved mechanisms Table 2Biological processes of wound healing and their key molecules and cell typesBiological ProcessMajor Cell TypesKey MoleculesSignaling PathwaysBiological FunctionTemporal PhaseReferencesImmunothrombosisEndothelial Cells, PlateletsHistones, VWFCalcium/Caspase PathwaysPromotes Platelet Adhesion and AggregationEarly/Acute Phase [67] Blood CoagulationPlatelets, LeukocytesEnzymatically Oxidized PhospholipidsLipoxygenase PathwaySeals Wound, Prevents InfectionHemostasis Phase [68] ECM Synthesis and DepositionHuman Dermal FibroblastsTGF-β1, pSmad2/3TGF-β1/Smad PathwayPromotes Collagen Synthesis and Cell ProliferationEarly Repair Phase [69] Early Angiogenesis and Late Anti-FibrosisEndothelial Cells, FibroblastsVEGF, TGF-βVEGF, TGF-βPromotes Healing, Prevents Scar FormationEarly and Late Phases [70] Myofibroblast Apoptosis and Scar ResolutionMyofibroblastsFibromodulin, IL-1βIL-1β Signaling PathwayInduces Apoptosis to Reduce Scar FormationPost-Wound Closure [71] Fibrosis and Regenerative HealingMyofibroblasts, MacrophagesTGF-β1, BCL-2TGF-β1 PathwayRegulates Inflammation and Fibrosis7 Days Post-Injury [72] Skin Wound HealingEndothelial Progenitor CellsSDF-1, CXCR4SDF-1/CXCR4 PathwayPromotes Wound RepairRepair Phase [73] Macrophage PolarizationMacrophagesLipin-1IL-4/STAT6/PPARγ PathwayPromotes Healing Phenotype TransitionLate Inflammatory Phase [74] Skin Wound HealingKeratinocytesFocal adhesion kinase (FAK)FAK Signaling PathwayPromotes Proliferation and DifferentiationRepair Phase [75] Chronic Wound HealingMacrophagesCytokines, Growth FactorsExtracellular Signal-Regulated Kinase (ERK) PathwayPromotes Angiogenesis, Anti-InflammatoryChronic/Repair Phase [76] Epidermal Wound HealingEpidermal CellsVacuolar H+-ATPaseERK Signaling PathwayActivates Repair GenesRepair Phase [77] Skin Inflammation/Wound HealingKeratinocytes, FibroblastsCannabidiol, NF-κBNF-κB Signaling PathwaySuppresses Inflammatory ResponseInflammatory Phase [78] Granulation tissue formation and cell proliferationDermal fibroblastsIGF-I, IGFBP-1IGF-I/ERK pathwayPromotes cell proliferation and tissue repairProliferative phase [79] Granulation tissue formation and wound contractionFibroblasts and myofibroblastsTGF-β, type I/III collagenTGF-β signaling pathwayPromotes tissue formation and contractionEarly proliferative phase [80] Inhibition of fibrosis and promotion of epithelializationKeratinocytes and fibroblastsFGF7, Fibroblast growth factor receptor 1 (FGFR1), FGFR2FGF/FGFR signaling pathwayInhibits scar formationProliferative/reconstruction phase [81] Angiogenesis and inflammatory responseEpithelial cells and endothelial cellsS100A12, KLF5, receptor for advanced glycation end products(RAGE)/Toll-like receptor 4 (TLR4)RAGE/TLR4 signaling pathwayImpairs endothelial function and delays wound healingInflammatory/proliferative phase [82] Endothelial cell migration and fibroblast activationEndothelial cells and fibroblastsSRY (sex-determining region Y)-box transcription factor 17 (SOX17), DNA methyltransferase 3 alpha (DNMT3α), TGF-βDNMT3α/SOX17/TGF-β pathwayPromotes cell migration and activationProliferative phase [83] Cell migration and proliferationKeratinocytes and fibroblastsAMP-IBP5, LRP1MAPK signaling pathwayPromotes cell migration and proliferationProliferative phase [84] Wound healing and tissue regenerationB cells, CD4+ T cells, and CD8+T cellsmiR-223-3p, miR-142a-5p, miR-144-3pErbB, FoxO, Hippo, and PI3K-Akt signaling pathwaysRegulates gene expression and promotes healingInflammatory phase [85] Note: This table summarizes key cellular and molecular events primarily in wound healing, with selected evidence from related tissue injury models where appropriate to illustrate conserved mechanisms Biological processes of wound healing and their key molecules and cell types Note: This table summarizes key cellular and molecular events primarily in wound healing, with selected evidence from related tissue injury models where appropriate to illustrate conserved mechanisms The role of the ECM in wound healing The ECM is a critical contributor to wound healing; it provides mechanical tension and a solid scaffold for cells to attach or migrate, in addition to guidance by regulating cell migration, proliferation, and differentiation through signaling via interactions with integrins (cell membrane-attached receptors). In the early stages of wound healing, the ECM guides a reparative response by inducing recruitment and activation of inflammatory cells. Local cytokines and growth factors induce cells to secrete ECM components, including fibrin, collagen, and MMPs, thus providing a favorable microenvironment that supports cell proliferation and directs their migration toward the wound area [86]. During the proliferative stage of healing, not only is the matrix laid down for new blood vessels to form, but fibroblasts and keratinocytes are also attracted by the matrix to migrate across it and produce more. Being one of the main components of the ECM, collagen presence or absence is crucial for proper functioning, including both strength and structural integrity [58]. Moreover, the ECM controls cellular behavior and mechanical signaling via interaction with cell surface receptors such as integrins and fibronectin, which is particularly essential for successful wound healing [87]. The ECM undergoes dynamic changes in both composition and structure during the wound healing process. During the final step of this process, ECM remodeling takes place, where existing matrix components are gradually replaced by newly secreted matrix. Dysregulation of matrix turnover may lead to scar formation, with the balance between MMPs and tissue inhibitors of metalloproteinases (TIMPs) being of particular importance for ECM remodeling [88]. In addition, gelatinized cornea-derived extracellular matrix (GelCodE) has a favorable effect on scar-free tissue regeneration during wound healing owing to its ECM-mimicking properties [89]. As potential immunomodulatory biomaterials, fibroblast-derived matrix (FDM) hydrogels can support host cell infiltration and the participation of macrophages for enhanced wound healing [90]. The ECM during the process of wound healing has a dual role by providing resistance to cells as well as facilitating its repair through several dynamic regulations. As ECM content increases, porous scaffolds can enhance cellular proliferation, migration, and survival, which will accelerate tissue regeneration [91]. In the field of regenerative medicine, a strategy that targets ECM synthesis and remodeling will be beneficial for directing efficient wound healing as well as preventing scar tissue formation or promoting tissue/organ regeneration [92, 93]. The role of growth factors (e.g., vascular endothelial growth factor [VEGF], TGF-β) in wound healing Growth factors like VEGF and TGF-β trigger angiogenesis, tissue repair, and regeneration during wound healing. VEGF is an important promoter of neovascularization, and its increase induces increased proliferation and migration rates as well as enhanced tube formation capacity in endothelial cells, leading to more rapid blood supply, oxygen transport, and nutrient supply to the damaged tissue during the healing process. A recent study noted that exogenous growth differentiation factor (GDF) 11 significantly promotes diabetic wound healing via activation of HIF-1α-VEGF/SDF-1α signaling [94]. The decreased amount of VEGF in the saliva of diabetic patients contributes to the impaired healing of extraction wounds, while the lack of VEGF in the tissue vicinity may account for an oral wound healing disorder related to diabetes [95]. Moreover, the overexpression of VEGF165 in fibroblasts can enhance early angiogenesis and granulation tissue formation, offering new therapeutic strategies for patients with impaired wound healing and providing potential support for gene therapy approaches [96]. Meanwhile, TGF-β is also critical in the wound healing procedure. Mediating fibroblast proliferation, migration, and collagen synthesis, TGF-β helps in granulation tissue formation that paves the way for underlying ECM remodeling and wound closure. In another study, the combined effect of TGF-β with other growth factors like fibroblast growth factor (FGF) results in synergistically increased ECM production while keeping cell migratory potential [97]. Yet over-activation of TGF-β signaling can result in disordered fibrosis and scar formation, a frequent malady during tissue repair. In addition, TGF-β1 induces fibroblast secretion of tenascin C via dendritic cells, a phenomenon which can be blocked using neutralizing antibodies and has been shown to occur in membrane nanotubes [98]. Both VEGF and TGF-β are important in the wound-healing process, not only separately, but also as a veritable system since they cooperate in an indispensable way. For instance, the exosomes from ASCs elevate expression of VEGF by activating basic FGF, which in turn can promote angiogenesis and wound healing [99]. IL-10 stimulates VEGF production, and as such augments angiogenesis and re-epithelialization, thereby accelerating the healing process [100]. VEGF and its receptors are also important in the regulation of edema in burn patients. Burn injury injures the skin and generates several mediators, which lead to neovascularization development; in this process, VEGF is a central point [101]. The previously described roles of VEGF and TGF-β as pivotal regulators of the wound healing process are indeed recognized; however, not only do they act independently in this regard, but rather they also synergistically cooperate to drive repair and regeneration through their mutual regulation. Figure 2 shows a schematic illustration of inflammation-mediated wound healing to highlight the multistage nature of wound healing and the dynamic interactions between immune responses, ECM components, and growth factors. As a start, the scheme explains the interactions of central cells and signaling molecules that occur during the four stages of the healing process: hemostasis, inflammation, proliferation, and remodeling. Related molecular mechanisms may be well established based on in-depth investigation of how to improve tissue regeneration; this finding will provide a theoretical foundation and clinical significance for reducing scar formation. Fig. 2Inflammation-mediated wound healing across sequential stages. This graphic illustrates the different phases of healing-hemostasis, inflammation, proliferation, and remodeling. The hemostasis phase is marked by platelet adhesion and aggregation, while the coagulation cascade initiates fibrin clotting. The inflammatory phase involves recruitment of macrophages, neutrophils, and mast cells, as well as cytokine release and neuroimmune bidirectional crosstalk mediated by CGRP and substance P, while the proliferation phase is characterized by fibroblast proliferation, keratinocyte migration to cover the wound area, angiogenesis, and ECM synthesis that are mainly controlled by growth factors such as VEGF or TGF-β. Collagen fibers are reorganized and ECM remodeling occurs in the remodeling phase, leading to increased tissue strength. Dysregulation of these processes can result in fibrosis, hypertrophic scarring, or impaired wound healing Inflammation-mediated wound healing across sequential stages. This graphic illustrates the different phases of healing-hemostasis, inflammation, proliferation, and remodeling. The hemostasis phase is marked by platelet adhesion and aggregation, while the coagulation cascade initiates fibrin clotting. The inflammatory phase involves recruitment of macrophages, neutrophils, and mast cells, as well as cytokine release and neuroimmune bidirectional crosstalk mediated by CGRP and substance P, while the proliferation phase is characterized by fibroblast proliferation, keratinocyte migration to cover the wound area, angiogenesis, and ECM synthesis that are mainly controlled by growth factors such as VEGF or TGF-β. Collagen fibers are reorganized and ECM remodeling occurs in the remodeling phase, leading to increased tissue strength. Dysregulation of these processes can result in fibrosis, hypertrophic scarring, or impaired wound healing The impact of inflammation on wound healing The beneficial role of moderate inflammation in promoting wound healing Moderate inflammation plays a crucial role in promoting wound healing by coordinating immune activation with tissue repair processes [102]. Rather than being purely detrimental, controlled inflammatory responses provide essential signals that regulate fibroblast proliferation, angiogenesis, and immune cell crosstalk, thereby creating a permissive microenvironment for regeneration. Macrophages represent central regulators in this process. For instance, CD206⁺ macrophages enhance glycoprotein non-metastatic melanoma protein B (Gpnmb)–positive fibroblast proliferation in a platelet-derived growth factor A (PDGF-A)–platelet-derived growth factor receptor alpha (PDGFRA)-dependent manner, indicating the importance of moderate inflammation in tissue repair [103]. Alternatively activated macrophages (M2a) and their exosomes are increasingly recognized as important regulators of tissue repair processes. In corneal endothelial cell models, M2a macrophages and their exosomes suppress inflammatory responses and promote cell proliferation, effects that can be further enhanced by epidermal growth factor (EGF) preconditioning [104]. In addition, reparative Ly6C-low macrophages contribute to tissue repair through GDF-15-mediated activation of the retinoid X receptor (RXR)/PPARγ pathway, highlighting the importance of macrophage subtype specialization during moderate inflammation [105]. Together, these findings suggest that macrophages act as central regulators that couple inflammatory signaling with tissue regeneration in a context-dependent manner. Moderate inflammation is consequently tightly coupled with metabolic and signaling regulation at the molecular level. For instance, andrographolide has been reported to facilitate photoaged skin repair through modulation of IL-1β and COX-2 signaling, which may coordinate with metabolic regulators (e.g., HIF-1α and PPARγ) to balance inflammation and tissue regeneration [106]. Furthermore, endothelial–immune crosstalk may play a role in controlling inflammation, given evidence from pulmonary models that endothelial-derived Rspondin3 can reprogram macrophages via the β-catenin–α-ketoglutarate–TET2 signaling axis to attenuate inflammatory injury [107]. Moderate inflammation can also be modulated by biomaterials and extracellular signals. For instance, porous titanium scaffolds (PTS) influence regenerative outcomes partly through extracellular vesicles (EVs), including small extracellular vesicles (sEVs), which mediate signaling to T cells, suggesting a role for material-immune interactions in regulating inflammation [108]. Similarly, calcium alginate dressings modulate macrophage polarization, balancing pro-inflammatory and pro-reparative responses to enhance healing outcomes [109]. Damage-associated factors such as MYDGF further regulate neutrophil migration and inflammatory signaling via the HIF-1α pathway, emphasizing the importance of microenvironmental cues in shaping moderate inflammation [110]. Collectively, these studies highlight that biomaterials and extracellular signals can actively modulate immune responses to maintain a pro-reparative inflammatory state. These findings collectively demonstrate that moderate inflammation is not merely a transition but an actively regulated state integrating immune signaling, metabolic adaptation, and microenvironmental interactions. Inflammatory responses play key roles in tissue repair, and disruption of inflammatory homeostasis may impede regeneration, thus emphasizing the need for precise modulation of inflammation in therapeutic strategies. Exploring the negative impact of excessive inflammation on the healing process and its underlying mechanisms During wound healing, inflammation serves as a primary defense mechanism against tissue injury [111]. Moderate inflammation promotes the removal of necrotic tissue and potential pathogens, which ultimately forms the basis for repair and healing. However, when inflammation becomes excessive or persists for prolonged periods, it disrupts the delicate balance required for effective tissue repair, resulting in delayed or impaired healing [112]. Generally, hyper-inflammation is characterized by the sustained accumulation of neutrophils, macrophages, and T cells, resulting in overproduction of ROS, proteases, and pro-inflammatory mediators. These agents not only exacerbate tissue damage but also affect the ECM as well as the vasculature of wounds, disrupting proper fibroblast and keratinocyte function such that endothelial cells lose ground to granulation tissue formation, while impairing the growth of vessels into wounds [113]. At the molecular level, dysregulated NF-κB and MAPK pathways can mediate persistent release of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. In addition to causing DNA, protein, and lipid damage with apoptosis/necrotic cell fate, oxidative stress also downregulates pro-repair molecules such as TGF-β, thereby providing a poor temporal sequence for the inflammation and repair process. Additionally, prolonged retention of macrophages in the M1 pro-inflammatory phenotype without timely transition to the reparative M2 phenotype constitutes another central mechanism underlying delayed wound healing [114, 115]. There have been numerous developments of intervention methods in recent years in order to address the pathways contributing to uncontrolled inflammation. As an example, palmitoylation of NLRP3 can enhance inflammasome activity and consequently IL-1β release to exacerbate inflammation in diabetic wound healing, which can be alleviated by phenylpyruvate interventions [113]. CLEC14A deficiency reduces angiogenesis and promotes a pro-inflammatory response, thereby impairing wound healing, whereas CLEC14A overexpression restores repair under hyperglycemic conditions [116]; moreover, pathological activation of the CERK-C1P axis exacerbated impaired healing through inflammatory cell signaling pathways, while blockade of this axis significantly improved the inflammatory microenvironment and accelerated wound closure [117]. Moreover, it is possible that inhibition of excessive inflammatory responses, scavenging of ROS, or modulation of immune cell phenotypes may optimize wound repair outcomes. For instance, sustained wound closure can be promoted by treatment strategies involving cyclodextrin-ferrocene/bletilla striata polysaccharide (BSP) hydrogel, valproic acid-loaded exosomes (VPA-EXO), hypoxia-preconditioned exosome-incorporated hydrogels (H-Exos-gel), bone morphogenetic protein 7 recombinant adenovirus (Ad-BMP7), and CAP-coated elastin-like recombinamer (ELR) hydrogels. These methods reduce pro-inflammatory cytokine levels and ROS production, or inhibit M1 macrophage polarization, thereby promoting angiogenesis and collagen deposition, both of which are critical for effective tissue regeneration [114, 118]. Meanwhile, immune regulation at the molecular and cellular levels also shows great potential. For example, overexpression of the miR-17 ~ 92 cluster suppresses inflammatory responses by inhibiting the TLR3/NF-κB pathway [119], subconjunctival injection of Tregs attenuates excessive inflammation and promotes corneal epithelial repair [43], and vitamin D supplementation may facilitate epithelial-mesenchymal transition (EMT) via activation of the Hippo (Yes-associated protein/transcriptional coactivator with PDZ-binding motif, YAP/TAZ) signaling pathway, thereby accelerating wound healing in aged skin [120]. Excessive inflammation disturbs the microenvironment of tissue repair through diverse mechanisms, including continual infiltration of immune cells, overproduction of inflammatory mediators, and aberrant activation of signaling pathways [45, 112]. The inhibition of inflammasome, modulation of signaling pathways, elimination of ROS, and regulation of immune phenotypes may represent promising strategies for targeted regulation of the inflammatory process, thus laying a theoretical and practical foundation for the effective treatment of chronic non-healing wounds and promotion of tissue repair. Excessive or unresolved inflammation eventually leads to impaired tissue regeneration and can promote the formation of chronic wounds by compromising immune homeostasis. The relationship between inflammation and infection and their impact on healing Inflammation and infection are inextricably associated with wound healing, with each contributing to the quality and efficacy of tissue repair. Infection pertains to the presence of pathogenic organisms that colonize an injury or tissue and cause inflammation. Frequent pathogens include Staphylococcus aureus, which is one of the most common pathogens associated with impaired wound healing [121, 122]. After injury, through vasodilatation, hyperaemia, and recruitment of inflammatory factors, the body triggers an initial inflammatory response in order to clear microorganisms within the network as well as necrotic tissue. Nevertheless, highly activated pathogen invasion or host defense could eventually lead to deregulation and result in an inflammatory response that is chronically activated or intensified by significant upregulation of local pro-inflammatory cytokines (i.e., TNF-α, IL-1β, and IL-6) as well as prolonged infiltration of damaged neutrophils and macrophages [123–125]. As immune cells remove pathogens, they also damage local ECM and vascular endothelium by ROS generation, secretion of proteases, and expression of adhesion molecules [126], which interferes with granulation tissue formation and epithelialization as well as inhibits proliferation of fibroblasts, collagen deposition and angiogenesis [127]. Consequently, wound healing is delayed, potentially leading to the formation of chronic wounds [128]. To overcome this, several novel antimicrobial and anti-inflammatory biomaterials have been developed to treat infection-associated excessive inflammation. The dopamine-grafted ε-poly-L-lysine/oxidized dextran hydrogel loaded with asiaticoside microspheres (EPL-DA/ODEX/AMs) effectively regulates infection and promotes wound healing owing to its combined antibacterial and anti-inflammatory activities [123]. In addition, a hyaluronic acid/tannic acid cryogel loaded with antimicrobial peptide KR-12 (HA/TA2/KR2) exhibits antioxidant and anti-inflammatory properties and serves as a delivery platform for KR-12 [124]; Negative air ions (NAIs) exert anti-inflammatory effects by upregulating LC3-II-mediated autophagy and downregulating Caspase-3/PARP-mediated apoptotic signaling; meanwhile, they accelerate wound healing by enhancing collagen deposition and angiogenesis via the VEGFR-2-mediated TGF-β1 signaling pathway [125]. Dressings such as Ag Nanocluster Hydrogel (NCH) [127], HMME@Lipo-PMB [126] and MCC@ZIF-8@Cur hydrogel [129] not only efficiently alleviate infection-related inflammation but also promote the healing process through their bactericidal function, macrophage M1/M2 polarization regulation and angiogenesis. Alternatively, as a new host defence and tissue repair–modulating factor, PCTR1 may provide an approach to better control delayed healing and infection [128]. Additionally, near-infrared (NIR) photothermal hydrogels [129, 130], Fe-SAzyme nanozyme [131], hyaluronic acid-tyramine conjugate (HTA) hydrogel [132], and poly(ethylene glycol)-poly(ε-caprolactone)-poly(ethylene glycol) (PECE) hydrogel [133] collectively improve the wound microenvironment by reducing ROS levels and suppressing pro-inflammatory cytokine production. At the heart of this work for efficient healing and functional restoration of infected wounds is understanding how inflammation and infection interact, and then controlling local inflammatory responses as well as pathogen burden using the next generation of materials and strategies. In order to highlight the bidirectional impact of inflammation in wound healing and its interplay with infection, Fig. 3 provides a schematic overview of both protective effects related to moderate inflammation, adverse outcomes caused by exaggerated inflammation, as well as major pathways and therapeutic approaches contributing to infection-associated wound repair. Fig. 3Dual roles of inflammation in wound healing and its interaction with infection. This schematic shows the dual role of inflammation during wound healing and its relationship with infection. Sustaining this pro-inflammatory tissue remodeling over time leads to exaggerated inflammation and fibrosis via unbalanced immune activity, monocyte polarization bias toward M1-type macrophage dominance, as well as dual metabolic regulation through HIF-1α/PPARγ networks mediating fibrotic (PDGF-A/PDGFRA) signal transduction, while moderate inflammation promotes tissue repair through coordinated immune regulation, macrophage polarization, fibroblast activation, and metabolic balance. In contrast, chronic or excessive inflammation results in tissue damage by prolonged infiltration of neutrophils, T cells, and M1-like macrophages, with overproduction of pro-inflammatory cytokines, ROS, and proteases, as well as downregulation of other pro-repair factors (e.g., TGF-β). As a consequence, ECM damage occurs, resulting in dysfunctions in the tissue regenerative process, impaired wound healing, and delayed repair. In pathologies of infection, Staphylococcus aureus and other pathogens amplify inflammatory mediators to elicit cascades of cytokine- and ROS-mediated tissue-damaging effects that compromise repair processes. Innovative therapeutic strategies, such as biomaterial-based platforms (e.g., hydrogels, nanozymes, and exosome-based approaches), can inhibit inflammation through modulating the host–pathogen interaction and create a pro-regenerative environment Dual roles of inflammation in wound healing and its interaction with infection. This schematic shows the dual role of inflammation during wound healing and its relationship with infection. Sustaining this pro-inflammatory tissue remodeling over time leads to exaggerated inflammation and fibrosis via unbalanced immune activity, monocyte polarization bias toward M1-type macrophage dominance, as well as dual metabolic regulation through HIF-1α/PPARγ networks mediating fibrotic (PDGF-A/PDGFRA) signal transduction, while moderate inflammation promotes tissue repair through coordinated immune regulation, macrophage polarization, fibroblast activation, and metabolic balance. In contrast, chronic or excessive inflammation results in tissue damage by prolonged infiltration of neutrophils, T cells, and M1-like macrophages, with overproduction of pro-inflammatory cytokines, ROS, and proteases, as well as downregulation of other pro-repair factors (e.g., TGF-β). As a consequence, ECM damage occurs, resulting in dysfunctions in the tissue regenerative process, impaired wound healing, and delayed repair. In pathologies of infection, Staphylococcus aureus and other pathogens amplify inflammatory mediators to elicit cascades of cytokine- and ROS-mediated tissue-damaging effects that compromise repair processes. Innovative therapeutic strategies, such as biomaterial-based platforms (e.g., hydrogels, nanozymes, and exosome-based approaches), can inhibit inflammation through modulating the host–pathogen interaction and create a pro-regenerative environment Therapeutic approaches and their translation Current anti-inflammatory therapeutic approaches The inflammatory response is necessary for wound repair but can also induce tissue damage. Moderate inflammation clears necrotic tissue debris and pathogens while stimulating angiogenesis, proliferation of cells, and matrix remodeling. Conversely, an overactive or prolonged inflammatory response could hinder healing and lead to fibrosis or chronic wounds. Hence, different anti-inflammatory strategies are adopted in clinical practice to optimize wound healing without impairing the defensive function of the wound and facilitate tissue repair [134, 135]. Negative Pressure-Platform Wound Device (NP-PWD) is a one-piece, simplified NPWT system that does not require filler materials. It is easy to use, and its transparency allows continuous visualization of the wound, which is an advantage compared with traditional NPWT. Mechanistically, it facilitates healing of diabetic foot ulcers (DFUs) by downregulating miR-155 expression in granulation tissue, which attenuates pro-inflammatory responses and modulates inflammatory mediators [136, 137]. Hyperbaric oxygen therapy (HBOT) can promote the healing of chronic DFUs faster than standard therapy, and thus has significant impact on long-term health-related quality of life in patients [138]. For the treatment of partial-thickness burns, a topical polyhexanide/betaine formulation leads to faster healing and lower pain than silver sulfadiazine with superior tolerability, and efficacy for wound management [139]; Octenidine dihydrochloride (OCT) shows general anti-inflammatory properties with protease inhibitory features accompanied by low cellular interference so that safety in wound repair is not affected [134]. The combination of autologous platelet-rich plasma (PRP) and advanced platelet-rich fibrin (A-PRF) with HA can markedly promote wound angiogenesis, reduce local inflammation, and enhance the healing process, thereby providing a cost-effective therapeutic strategy for DFUs [140, 141]. OCT can suppress the induction of Langerhans cell maturation marker CD83 and inhibit the release of both pro- and anti-inflammatory mediators (IL-8, IL-33, IL10), while promoting the maintenance of angiogenic factors in the wound healing process (VEGF and TGFb1), which contributes to a fine-tuning of inflammation with functional preservation for tissue repair [135]. These drugs, local physical interventions, as well as biologics represent multi-level strategies for modulating wound inflammation; however, their clinical effectiveness critically depends on dose, timing, and duration. Excessive suppression of early inflammatory responses may impair pathogen clearance, debris removal, and the initiation of angiogenesis and tissue repair, while insufficient regulation may allow inflammation to persist and become pathological. Thus, defining an appropriate therapeutic window remains a major challenge for translating anti-inflammatory strategies into clinical practice. Emerging therapeutic strategies Many promising novel approaches to wound healing have emerged recently due to the development of molecular biology, regenerative medicine and bioengineering. Emerging strategies can be broadly compared across distinct functional categories. Inflammation-modulating strategies, including IL-10-based therapies or macrophage polarization approaches, primarily focus on dampening excessive release of inflammatory cytokines while promoting angiogenic signaling, suggesting they may be beneficial for inflamed wound [142]; importantly, excessive suppression of inflammation may impair early healing, underscoring the need for precise control of intervention timing and intensity. However, these benefits may be limited when microbial burden, ischemia, or matrix loss is the dominant barrier to healing. Biomaterial-based and nanotechnology-enabled systems, including multifunctional hydrogels such as gelatin methacrylate (GelMA) or those based on HA, show advantages in localized delivery, prolonged retention, and the integration of antimicrobial, antioxidant, and pro-regenerative functionalities [143]; their clinical translation still faces challenges related to formulation complexity, manufacturing standardization, and regulatory considerations [144]. Small-molecule pro-regenerative strategies like deferoxamine (DFO) or metformin may promote re-epithelialization and tissue growth, but are likely to be less effective if impairment in inflammatory microenvironment control has not been previously addressed [145]. Consequently, these modalities are complementary rather than interchangeable, targeting distinct rate-limiting steps. Table 3 compares their mechanisms, applications, maturity, and limitations, highlighting differences in efficacy and feasibility, and reflecting a shift of negative pressure systems toward integrated, targeted repair. Table 3Therapeutic approaches for wound healing and their translational strategiesTherapeutic approachPrimary mechanismIndicationsClinical outcomesDevelopment stageTranslational applicationTranslational advantageKey limitationReferencesNPWTi-dNegative pressure drainage combined with instillation for wound cleansingAcute traumatic wounds (e.g., traffic injuries)Shortens wound closure time and reduces the number of surgical interventionsRandomized controlled clinical trialApplied in acute trauma wound managementEnhances wound bed preparation efficiency and reduces surgical burdenLimited high-quality multicenter evidence; cost-effectiveness and long-term outcomes require further validation [146] ciNPWTImproves oxygenation and microcirculation at the incision marginsPostoperative management after large soft tissue tumor resectionReduces drainage volume and wound-related complicationsRandomized controlled trialApplied in wound management following tumor resectionImproves perfusion at incision margins and reduces complication risk in high-risk surgical woundsLimited sample size; evidence mainly from specific surgical populations; generalizability requires further validation [147] NPWTPromotes granulation tissue formation and wound closureImpaired postoperative abdominal wound healingHigher healing rate and shorter healing timeMulticenter randomized clinical trialEnables continuity of care from inpatient to outpatient settingsFacilitates outpatient management and reduces overall treatment durationMay prolong hospital stay due to logistical and infrastructure limitations; requires specialized care and equipment [148] Bone Marrow–Derived Mesenchymal Stem Cells (BMSCs) + NPWTNPWT enhances the pro-angiogenic effect of BMSCsComplex and large-area skin woundsEnhances angiogenesis and cell survivalPreclinical animal studyTreatment of refractory and complex woundsSynergistic effect combining regenerative cell therapy with mechanical stimulation, improving vascularization and tissue regenerationLack of clinical trials; challenges in cell delivery, survival, and standardization [149] NPWTAccelerates wound re-epithelializationPediatric patients with small-area burnsFaster healing with lower treatment costsRandomized controlled trialCost-effective adjunctive therapy for burn managementReduces healing time and healthcare costs while minimizing need for surgical interventionsEvidence mainly from small-area burns; generalizability to large or severe burns requires further validation [150] Sutureless NPWT-based skin graft fixationFixes the skin graft onto the wound bed using negative pressurePatients undergoing split-thickness skin graftingComparable graft survival rate with reduced operative time and avoidance of graft shearingClinical controlled studySimplifies the skin graft fixation procedureEliminates need for sutures or staples, reducing procedure time and patient discomfortSmall sample size and lack of randomized controlled trials; limited statistical power [151] NPWTImproves perfusion and modulates inflammation to promote healingPreoperative preparation for chronic DFU graftingReduces preoperative time and increases graft survival rateRandomized controlled trialServes as an optimized approach prior to DFU skin graftingEnhances graft success through improved vascularization and modulation of inflammatory microenvironmentSingle-center study; limited sample size; lack of long-term follow-up [152] NPWT with irrigationPeriodic irrigation combined with negative pressure promotes healingInfected wounds requiring inpatient surgical debridementSaline and antimicrobial solutions showed comparable efficacy, with shorter time to final surgeryProspective randomized clinical studyAdjunctive management of hospitalized infected woundsProvides effective wound management with flexible and cost-effective solution selectionLack of standard control group and heterogeneity of wound types [153] Allogeneic Fibroblast-based Skin Substitute (Alloskin)Provides fibroblasts to enhance wound healing activityThird-degree burn woundsSignificantly accelerates healing time and reduces scar formationClinical controlled studyAdjunctive therapy for extensive burns with insufficient autologous skin availabilityMay reduce reliance on autologous grafts and improve cosmetic outcomesSmall sample size and lack of large-scale randomized validation [154] Pelnac Dermal Template Combined with VSD and Skin GraftingProvides dermal matrix; negative pressure promotes granulation tissue formationExtensive skin and soft tissue defects of the foot and ankle13 out of 16 grafts achieved full survival with good functional recoverySingle-center clinical case series studyEffective treatment for complex wounds with exposed bone or tendonEnables reconstruction of challenging wounds with good functional recovery and low complication ratesSmall sample size and lack of control group [155] Table 3Therapeutic approaches for wound healing and their translational strategiesTherapeutic approachPrimary mechanismIndicationsClinical outcomesDevelopment stageTranslational applicationTranslational advantageKey limitationReferencesNPWTi-dNegative pressure drainage combined with instillation for wound cleansingAcute traumatic wounds (e.g., traffic injuries)Shortens wound closure time and reduces the number of surgical interventionsRandomized controlled clinical trialApplied in acute trauma wound managementEnhances wound bed preparation efficiency and reduces surgical burdenLimited high-quality multicenter evidence; cost-effectiveness and long-term outcomes require further validation [146] ciNPWTImproves oxygenation and microcirculation at the incision marginsPostoperative management after large soft tissue tumor resectionReduces drainage volume and wound-related complicationsRandomized controlled trialApplied in wound management following tumor resectionImproves perfusion at incision margins and reduces complication risk in high-risk surgical woundsLimited sample size; evidence mainly from specific surgical populations; generalizability requires further validation [147] NPWTPromotes granulation tissue formation and wound closureImpaired postoperative abdominal wound healingHigher healing rate and shorter healing timeMulticenter randomized clinical trialEnables continuity of care from inpatient to outpatient settingsFacilitates outpatient management and reduces overall treatment durationMay prolong hospital stay due to logistical and infrastructure limitations; requires specialized care and equipment [148] Bone Marrow–Derived Mesenchymal Stem Cells (BMSCs) + NPWTNPWT enhances the pro-angiogenic effect of BMSCsComplex and large-area skin woundsEnhances angiogenesis and cell survivalPreclinical animal studyTreatment of refractory and complex woundsSynergistic effect combining regenerative cell therapy with mechanical stimulation, improving vascularization and tissue regenerationLack of clinical trials; challenges in cell delivery, survival, and standardization [149] NPWTAccelerates wound re-epithelializationPediatric patients with small-area burnsFaster healing with lower treatment costsRandomized controlled trialCost-effective adjunctive therapy for burn managementReduces healing time and healthcare costs while minimizing need for surgical interventionsEvidence mainly from small-area burns; generalizability to large or severe burns requires further validation [150] Sutureless NPWT-based skin graft fixationFixes the skin graft onto the wound bed using negative pressurePatients undergoing split-thickness skin graftingComparable graft survival rate with reduced operative time and avoidance of graft shearingClinical controlled studySimplifies the skin graft fixation procedureEliminates need for sutures or staples, reducing procedure time and patient discomfortSmall sample size and lack of randomized controlled trials; limited statistical power [151] NPWTImproves perfusion and modulates inflammation to promote healingPreoperative preparation for chronic DFU graftingReduces preoperative time and increases graft survival rateRandomized controlled trialServes as an optimized approach prior to DFU skin graftingEnhances graft success through improved vascularization and modulation of inflammatory microenvironmentSingle-center study; limited sample size; lack of long-term follow-up [152] NPWT with irrigationPeriodic irrigation combined with negative pressure promotes healingInfected wounds requiring inpatient surgical debridementSaline and antimicrobial solutions showed comparable efficacy, with shorter time to final surgeryProspective randomized clinical studyAdjunctive management of hospitalized infected woundsProvides effective wound management with flexible and cost-effective solution selectionLack of standard control group and heterogeneity of wound types [153] Allogeneic Fibroblast-based Skin Substitute (Alloskin)Provides fibroblasts to enhance wound healing activityThird-degree burn woundsSignificantly accelerates healing time and reduces scar formationClinical controlled studyAdjunctive therapy for extensive burns with insufficient autologous skin availabilityMay reduce reliance on autologous grafts and improve cosmetic outcomesSmall sample size and lack of large-scale randomized validation [154] Pelnac Dermal Template Combined with VSD and Skin GraftingProvides dermal matrix; negative pressure promotes granulation tissue formationExtensive skin and soft tissue defects of the foot and ankle13 out of 16 grafts achieved full survival with good functional recoverySingle-center clinical case series studyEffective treatment for complex wounds with exposed bone or tendonEnables reconstruction of challenging wounds with good functional recovery and low complication ratesSmall sample size and lack of control group [155] Therapeutic approaches for wound healing and their translational strategies The potential of personalized medicine in wound healing Stratified therapeutic strategies in wound healing are increasingly driven by the recognition that inflammatory responses are highly heterogeneous across patients and wound types, highlighting the importance of personalized medicine [156]. Current advances can be broadly categorized into three major axes of research, microbial stratification, inflammatory biomarker profiling, and spatial or multi-omics characterization of the local repair niche. These approaches differ substantially in both clinical readiness and biological resolution. Microbial profiling provides critical insight into pathogen burden and ecological complexity, particularly in biofilm-dominated wounds, but it does not fully capture the host inflammatory state, which plays a critical role in wound healing [157]. In contrast, inflammatory biomarkers such as CRP, IL-6, TNF-α, MMPs, or cytokine ratios reflect immune activation patterns and may enable monitoring of wound progression, although their specificity may be influenced by systemic conditions [158, 159]. At a higher resolution, single-cell, spatial transcriptomic, and proteomic approaches offer mechanistic insight into dysregulated inflammatory niches [160], including impaired keratinocyte migration, persistent macrophage activation, or failure of inflammation resolution. However, their routine clinical application remains limited by cost, technical complexity, and lack of standardization. Emerging machine learning strategies have been developed that integrate multi-layered molecular and clinical data to stratify patients according to inflammation-associated molecular profiles. Such data-driven insights could enable precision-guided interventions, including infection-informed therapeutic strategies and biomarker-guided immunomodulation [158, 161]. Altogether, these advances enable a shift toward inflammation-informed, precision-guided wound management based on molecular profiling. Table 4 integrates stages, mechanisms, and therapeutic targets with translational implications, while Fig. 4 summarizes current and emerging personalized strategies. Table 4Integrated mapping of inflammatory mechanisms, healing stages and therapeutic targets in wound repairInflammatory stageDominant immune/metabolic featuresKey pathwaysDysfunctionTherapeutic targetsTranslational implicationReferencesEarly inflammatory phase transitioning to the proliferative phasePersistent neutrophil infiltration; reduced monocyte-derived macrophage differentiation; impaired resolution of inflammationAngptl4-ifi202b regulatory axis; JAK/STAT, S6K, CDK signaling; TLR, NOTCH and SMAD pathwaysProlonged inflammation; defective monocyte-to-macrophage differentiation; delayed wound closureAngptl4; ifi202bTargeting Angptl4 signaling or modulating ifi202b expression may restore immune balance and accelerate healing in chronic wounds [162] Early inflammatory stage of diabetic wound repairIncreased NET formation and EndMT with impaired angiogenesisTLR-9/PAK2/Merlin/NF2/Hippo-YAP/SMAD2 signalingDelayed wound closure and reduced wound perfusionNETosis, PAD4/Padi4, SMAD2NETosis inhibition and SMAD2 knockdown accelerated diabetic wound healing by reducing EndMT and promoting angiogenesis [17] Inflammatory phase of wound healing with transition toward resolutionSustained neutrophil infiltration with polarization toward anti-inflammatory N2 phenotype; reduced ROS, NET formation, and TNF production; increased VEGF production; suppression of pentose phosphate pathwaycPLA2-C1P-eicosanoid axis; increased 5-HETE and 5-oxo-ETE biosynthesis; OXER1 signaling; downstream MAPK pathway; inhibition of pentose phosphate pathwayC1P-cPLA2 interaction promotes proinflammatory N1 polarization and impairs resolution, contributing to delayed healingcPLA2-C1P interaction; CERK; oxoeicosanoid pathway (5-HETE/5-oxo-ETE); OXER1; pentose phosphate pathway enzymes (e.g., PGD)Disruption of C1P-cPLA2 interaction or enhancement of 5-HETE/5-oxo-ETE signaling promotes N2 polarization, improves wound healing, and enhances survival in sepsis models [163] Inflammation to proliferation transition in diabetic wound healingPersistent pro-inflammatory macrophage activity with impaired M1-to-M2 transition; enhanced BMSC recruitment and neurogenesis-angiogenesis crosstalk after interventionMg²⁺-mediated BMSC recruitment via IL-8 and CCL5; sEV-induced macrophage reprogramming; downregulation of HIF-1, NF-κB, and PPAR; upregulation of PI3K and VEGF signalingProlonged inflammation and impaired transition to regenerative phaseMg²⁺, didymin-loaded ginseng-derived sEVs, macrophage reprogramming, neurogenesis–angiogenesis couplingInjectable hydrogel system promoted inflammation resolution, enhanced angiogenesis and neurogenesis, and accelerated diabetic wound healing [164] Inflammatory to regenerative transition in diabetic wound healingPro-inflammatory macrophage dominance; glucolipid metabolism-driven polarization toward CD206⁺/Arg-1⁺ phenotypeGlucolipid metabolic reprogramming; VEGF and IL-10 upregulationExcessive inflammation and impaired regenerative microenvironmentSAGs; macrophage metabolic reprogrammingSAGs-based system promoted angiogenesis, reduced inflammation, and enhanced diabetic wound repair [165] Inflammatory phase with transition to remodeling in diabetic wound healingPersistent inflammatory cell infiltration and elevated pro-inflammatory cytokines; reduced inflammation after interventionDownregulation of Il-1β, Il-6, and Tnf; modulation of MMP-9/Timp-1 ratioChronic inflammation and impaired ECM remodelingPlasma-activated water (PAW); inflammatory cytokines; MMP-9/TIMP-1 balancePAW reduced inflammation, improved collagen deposition, and accelerated diabetic wound healing [166] Inflammatory phase with impaired transition in diabetic wound healingPro-inflammatory macrophage activation with reduced M2 polarization; restoration of M2 phenotype after interventionInhibition of NLRP3 inflammasome activationPersistent inflammation and impaired fibroblast migrationAloe vera polysaccharides (APs); NLRP3 inflammasome; macrophage polarizationAPs reduced inflammation, promoted angiogenesis and wound closure in diabetic wounds [167] Inflammatory phase of infected burn wound healingPersistent infection, excessive ROS and inflammation; macrophage polarization toward M2 phenotype after interventionROS-responsive boronate bond cleavage; antimicrobial peptide release; VEGF-mimetic peptide-mediated pro-angiogenic signalingInfection-driven inflammation, oxidative stress, and impaired tissue regenerationAMP@GPQCD hydrogel; antimicrobial peptides; ROS modulation; macrophage polarization; VEGF-mimetic peptideHydrogel achieved antibacterial, anti-inflammatory, antioxidant and pro-angiogenic effects, promoted collagen remodeling and accelerated infected burn wound healing [168] Inflammatory phase of infected wound healingBacterial toxin-induced inflammation and tissue damage; elevated pro-inflammatory cytokines and abnormal collagen depositionPFT (α-hemolysin) neutralization via ADAM10-mediated adsorption; suppression of TNF-α, IL-1β and IL-6; inhibition of fibroblast-to-myofibroblast transition (α-SMA)Toxin-driven inflammation, apoptosis, and fibrosis leading to delayed healing and scar formationCell-mimicking liposomes; berberine (BBR); nintedanib (Ofev); PFTsLiposome system neutralized toxins, reduced inflammation and fibrosis, eradicated pathogens, and promoted scarless wound healing [169] Inflammatory to proliferative and remodeling phases of wound healingDysregulated inflammatory response, impaired angiogenesis and cell proliferation in early stagesPI3K-Akt, MAPK, cytokine-cytokine receptor interaction, NF-κB and AMPK pathwaysInadequate microenvironmental regulation leading to delayed healing and incomplete tissue regenerationSpatiotemporally controlled delivery of PDGF-BB, VEGF and EGF via nanofiber scaffoldScaffold modulated inflammation, enhanced angiogenesis, cell proliferation and ECM remodeling, achieving accelerated and scarless wound healing in large-animal models [170] Inflammatory phase of wound healingIncreased pro-inflammatory cytokines and lipid peroxidation; ferroptosis activation and lipid metabolism disorderTLR4/MyD88/NF-κB pathway; NLRP3/caspase-1/GSDMD pathway; AGE-RAGE-SREBP axis; PPARα/γ signaling; ferroptosis regulationPersistent inflammation, oxidative stress imbalance and lipid peroxidation leading to impaired healingMailuo Shutong Pill (MLSTP); ferroptosis; lipid metabolism pathwaysMLSTP reduced inflammation and lipid peroxidation, inhibited ferroptosis, and accelerated wound healing [171] Table 4Integrated mapping of inflammatory mechanisms, healing stages and therapeutic targets in wound repairInflammatory stageDominant immune/metabolic featuresKey pathwaysDysfunctionTherapeutic targetsTranslational implicationReferencesEarly inflammatory phase transitioning to the proliferative phasePersistent neutrophil infiltration; reduced monocyte-derived macrophage differentiation; impaired resolution of inflammationAngptl4-ifi202b regulatory axis; JAK/STAT, S6K, CDK signaling; TLR, NOTCH and SMAD pathwaysProlonged inflammation; defective monocyte-to-macrophage differentiation; delayed wound closureAngptl4; ifi202bTargeting Angptl4 signaling or modulating ifi202b expression may restore immune balance and accelerate healing in chronic wounds [162] Early inflammatory stage of diabetic wound repairIncreased NET formation and EndMT with impaired angiogenesisTLR-9/PAK2/Merlin/NF2/Hippo-YAP/SMAD2 signalingDelayed wound closure and reduced wound perfusionNETosis, PAD4/Padi4, SMAD2NETosis inhibition and SMAD2 knockdown accelerated diabetic wound healing by reducing EndMT and promoting angiogenesis [17] Inflammatory phase of wound healing with transition toward resolutionSustained neutrophil infiltration with polarization toward anti-inflammatory N2 phenotype; reduced ROS, NET formation, and TNF production; increased VEGF production; suppression of pentose phosphate pathwaycPLA2-C1P-eicosanoid axis; increased 5-HETE and 5-oxo-ETE biosynthesis; OXER1 signaling; downstream MAPK pathway; inhibition of pentose phosphate pathwayC1P-cPLA2 interaction promotes proinflammatory N1 polarization and impairs resolution, contributing to delayed healingcPLA2-C1P interaction; CERK; oxoeicosanoid pathway (5-HETE/5-oxo-ETE); OXER1; pentose phosphate pathway enzymes (e.g., PGD)Disruption of C1P-cPLA2 interaction or enhancement of 5-HETE/5-oxo-ETE signaling promotes N2 polarization, improves wound healing, and enhances survival in sepsis models [163] Inflammation to proliferation transition in diabetic wound healingPersistent pro-inflammatory macrophage activity with impaired M1-to-M2 transition; enhanced BMSC recruitment and neurogenesis-angiogenesis crosstalk after interventionMg²⁺-mediated BMSC recruitment via IL-8 and CCL5; sEV-induced macrophage reprogramming; downregulation of HIF-1, NF-κB, and PPAR; upregulation of PI3K and VEGF signalingProlonged inflammation and impaired transition to regenerative phaseMg²⁺, didymin-loaded ginseng-derived sEVs, macrophage reprogramming, neurogenesis–angiogenesis couplingInjectable hydrogel system promoted inflammation resolution, enhanced angiogenesis and neurogenesis, and accelerated diabetic wound healing [164] Inflammatory to regenerative transition in diabetic wound healingPro-inflammatory macrophage dominance; glucolipid metabolism-driven polarization toward CD206⁺/Arg-1⁺ phenotypeGlucolipid metabolic reprogramming; VEGF and IL-10 upregulationExcessive inflammation and impaired regenerative microenvironmentSAGs; macrophage metabolic reprogrammingSAGs-based system promoted angiogenesis, reduced inflammation, and enhanced diabetic wound repair [165] Inflammatory phase with transition to remodeling in diabetic wound healingPersistent inflammatory cell infiltration and elevated pro-inflammatory cytokines; reduced inflammation after interventionDownregulation of Il-1β, Il-6, and Tnf; modulation of MMP-9/Timp-1 ratioChronic inflammation and impaired ECM remodelingPlasma-activated water (PAW); inflammatory cytokines; MMP-9/TIMP-1 balancePAW reduced inflammation, improved collagen deposition, and accelerated diabetic wound healing [166] Inflammatory phase with impaired transition in diabetic wound healingPro-inflammatory macrophage activation with reduced M2 polarization; restoration of M2 phenotype after interventionInhibition of NLRP3 inflammasome activationPersistent inflammation and impaired fibroblast migrationAloe vera polysaccharides (APs); NLRP3 inflammasome; macrophage polarizationAPs reduced inflammation, promoted angiogenesis and wound closure in diabetic wounds [167] Inflammatory phase of infected burn wound healingPersistent infection, excessive ROS and inflammation; macrophage polarization toward M2 phenotype after interventionROS-responsive boronate bond cleavage; antimicrobial peptide release; VEGF-mimetic peptide-mediated pro-angiogenic signalingInfection-driven inflammation, oxidative stress, and impaired tissue regenerationAMP@GPQCD hydrogel; antimicrobial peptides; ROS modulation; macrophage polarization; VEGF-mimetic peptideHydrogel achieved antibacterial, anti-inflammatory, antioxidant and pro-angiogenic effects, promoted collagen remodeling and accelerated infected burn wound healing [168] Inflammatory phase of infected wound healingBacterial toxin-induced inflammation and tissue damage; elevated pro-inflammatory cytokines and abnormal collagen depositionPFT (α-hemolysin) neutralization via ADAM10-mediated adsorption; suppression of TNF-α, IL-1β and IL-6; inhibition of fibroblast-to-myofibroblast transition (α-SMA)Toxin-driven inflammation, apoptosis, and fibrosis leading to delayed healing and scar formationCell-mimicking liposomes; berberine (BBR); nintedanib (Ofev); PFTsLiposome system neutralized toxins, reduced inflammation and fibrosis, eradicated pathogens, and promoted scarless wound healing [169] Inflammatory to proliferative and remodeling phases of wound healingDysregulated inflammatory response, impaired angiogenesis and cell proliferation in early stagesPI3K-Akt, MAPK, cytokine-cytokine receptor interaction, NF-κB and AMPK pathwaysInadequate microenvironmental regulation leading to delayed healing and incomplete tissue regenerationSpatiotemporally controlled delivery of PDGF-BB, VEGF and EGF via nanofiber scaffoldScaffold modulated inflammation, enhanced angiogenesis, cell proliferation and ECM remodeling, achieving accelerated and scarless wound healing in large-animal models [170] Inflammatory phase of wound healingIncreased pro-inflammatory cytokines and lipid peroxidation; ferroptosis activation and lipid metabolism disorderTLR4/MyD88/NF-κB pathway; NLRP3/caspase-1/GSDMD pathway; AGE-RAGE-SREBP axis; PPARα/γ signaling; ferroptosis regulationPersistent inflammation, oxidative stress imbalance and lipid peroxidation leading to impaired healingMailuo Shutong Pill (MLSTP); ferroptosis; lipid metabolism pathwaysMLSTP reduced inflammation and lipid peroxidation, inhibited ferroptosis, and accelerated wound healing [171] Integrated mapping of inflammatory mechanisms, healing stages and therapeutic targets in wound repair Fig. 4Therapeutic approaches and their translational pathways in inflammation-modulated wound healing. This schematic outlines the landscape of targeting inflammation in diverse contexts across wound healing and highlights (A) current clinical methodologies for balancing beneficial and excessive inflammation, (B) cutting-edge bioengineered and regenerative strategies leveraging biomaterial-based systems and inflammation-modulating approaches, and (C) precision-guided, patient-specific therapies informed by microbial profiling, inflammatory biomarkers, and multi-omics characterization. In concert, these strategies exemplify the transition from empirical treatment to targeted and personalized wound management Therapeutic approaches and their translational pathways in inflammation-modulated wound healing. This schematic outlines the landscape of targeting inflammation in diverse contexts across wound healing and highlights (A) current clinical methodologies for balancing beneficial and excessive inflammation, (B) cutting-edge bioengineered and regenerative strategies leveraging biomaterial-based systems and inflammation-modulating approaches, and (C) precision-guided, patient-specific therapies informed by microbial profiling, inflammatory biomarkers, and multi-omics characterization. In concert, these strategies exemplify the transition from empirical treatment to targeted and personalized wound management Challenges and opportunities in clinical translation Barriers to the clinical translation of inflammation and wound healing research Spatial transcriptomics of human burn samples show this is the case; the microenvironment over space changes and one therapy might not work in the same way for different parts of a wound or during healing even when it corresponds to measures that are overall effective [172]. Patient-specific genetic control of tissue expression defines the composition of the wound microbiome, indicating that unique host–microbe interactions may impede the clinical reproducibility of standardized therapies [173]. Chronic wounds are highly heterogeneous, and microbial biofilms represent a significant translational challenge in this context. Instead of simply serving as a reservoir for chronic infection, biofilms hold the wound in a self-perpetuating state of inflammation by providing an ongoing stimulus to neutrophil and macrophage activation, increasing protease and ROS burden, while also protecting microbes from both host clearance and antimicrobial treatment [174]. Consequently, the wound fails to transition efficiently from the inflammatory phase to the proliferative phase, with impaired keratinocyte migration, fibroblast activity, angiogenesis, and granulation tissue formation [175]. This limitation extends to the predictive value of many preclinical models, which do not adequately reproduce mature polymicrobial biofilms or their spatially heterogeneous interaction with host immunity. Thus, effective clinical translation demands not only anti-inflammatory modulation, but also strategies capable of disrupting biofilm architecture and restoring phase transition toward proliferation [176]. Systemic effects on peripheral immune pathways are manifested in these severely unwell patients, and these effects demonstrate a lack of robustness around potential biomarkers and stratification strategies, undermining the uniformity of clinical trial recruitment, exclusion criteria and efficacy assessment [177]. Single-cell and transcription factor (TF) activity studies find that the macrophage lineages are dynamically heterogeneous across wound healing phases, which makes it challenging to recreate temporal–phenotypic immune targeting clinically [178]. Cross-species comparisons of regenerative vs. non-regenerative models show that tissue-specific gene and ECM composition differences predict healing outcomes, so there should be a conservative translation of findings from animals to humans and a need for validation layers [179]. Even the most promising new technologies, despite encouraging results from small randomized trials, tend to be constrained by limited sample size, follow-up duration, and lack of standardization, such that the evidence may fall short of regulatory or clinical adoption thresholds [180]. Similarly, some physical or device-based treatments have primarily been evaluated in small pilot or single-center studies. Although preliminary findings suggest potential clinical benefits, evidence linking therapeutic efficacy to underlying biological markers remains limited and largely exploratory, warranting further validation in larger, multicenter trials [181]. Home-based interventions may improve accessibility; however, challenges in adherence, remote quality control, and consistent outcome assessment continue to limit their scalability [182]. Prospects for emerging technologies in wound healing The simultaneous anti-inflammatory and pro-angiogenic effects of drug-loaded microneedles could be achieved in diabetic models. For example, 6-gingerol-encapsulated microneedles could facilitate collagen deposition and macrophage lineage remodeling in a targeted manner [183]. The intelligent/functional MNs hasten cellular migration and blood vessel formation through sustained release of redox or ionic signals, achieving a macroscale low-cost/pain-controllable local therapeutic platform for chronic wounds. Immune-driven strategies, such as the locally controlled release of injectable exosome hydrogels in diabetic wounds, demonstrate a reduction of the remaining wound area indicative of closed-loop interventions using biological carriers and regenerative signaling. Both thermosensitive and NIR-responsive antimicrobial hydrogels inhibit bacterial growth in vivo and exhibit wound-healing effects with the multi-target function of scavenging ROS and protecting from hypoxia, and could be used for complex infected wounds [184]. Photothermal-metabolic dual-pathway hydrogel promotes diabetes wound healing by regulating Staphylococcus aureus energy metabolism and immune microenvironment. Photothermal hydrogels have the characteristics of stretchability and adhesiveness and self-heal, which can accelerate animal wound re-epithelialization and closure with NIR aid, suggesting that it is possible to couple it with portable light sources [185]. The anti-biofilm/photothermal composite hydrogels hold potential to eliminate drug-resistant biofilms as well as to promote host clearance, providing more material choices for the treatment of recalcitrant infections and exudation wounds [186]. Tissue-adaptive, NIR-responsive hydrogel shows long-term stability and enhances wound closure in harsh environment models, suggesting the importance of material-tissue coupling strategies [187]. At the translational level, randomized controlled trials on single-use non-electronic negative pressure systems have demonstrated their efficacy and clinical use in surgical wound management, providing strong evidence for large-scale implementation of smart consumables [188]. Various novel approaches have been employed for modulation of inflammation and promotion of wound healing in concert with the advances made in regenerative medicine and bioengineering. An integrated perspective across emerging technological toolkits presents representative multi-level intervention strategies from EVs to smart dressings and suggests different future directions for precision repair. These interdisciplinary advances not only promote the development of wound treatment from passive repair to active regeneration, but also provide a theoretical basis for personalized and intelligent tissue reconstruction. The importance of multidisciplinary collaboration in translating research findings Multidisciplinary collaboration has an important role in translating research findings into clinical practice. In combination, the finding of strain-level dynamics in time-series metagenomic studies of the ulcer microbiome being associated with healing outcomes suggests a role for integration of multi-omics monitoring into clinical follow-up to guide intervention timing. These advances are contingent on close collaboration between surgical, infectious disease, and genomics-based teams [189]. After the advent of multidisciplinary diabetic foot care teams, regional pre- and post-intervention studies have shown a reduction in major amputation rates, suggesting that with appropriate triage of patients and adequate management of their complications there can be a return to essential clinical indicators [190]. Studies of facility-level variability in rates of amputation based on Veterans Affairs data have shown substantial disparities, emphasizing the impact of organizational processes and team functionality and advocating for system-level interventions [191]. The introduction of standardized clinical pathways to complement a hospital-based service has been associated with reduced rates of major amputation, length of stay, and cost, suggesting that pathway-based care either within or between different specialties enhances efficiency and affordability [192]. Resource utilization investigations have shown negative pressure therapy to potentially be superior compared to standard care in facilitating efficient allocation of healthcare resources across outpatient and inpatient settings, with the key being collaboration between clinical, economic, and engineering assessments [193]. Emergency fast-track pathways and a team-based approach have previously been reported in the literature, with practice-based studies demonstrating a reduction in major amputation rates, indicating that regional multidisciplinary coordination is feasible even outside clinical trials and that outcomes can improve over time [194]. Intervention studies have also highlighted critical challenges involving collaborators and implementers (such as frontline podiatrists), particularly in sustaining the resources required for effective cross-level teamwork, which further underscores the importance of integrating clinical practice with emerging molecular and data-driven approaches [195]. Metagenomic next-generation sequencing (NGS) of diabetic foot (DF) samples has demonstrated a higher detection rate and a broader spectrum of pathogens compared with conventional culture, which can guide targeted anti-infective strategies. This strategy is spearheaded by close collaboration between clinicians and molecular laboratories [196]. In chronic wound cohorts, the temporal robustness of microbial communities is associated with clinical outcomes, providing preliminary evidence that cross-disciplinary phenotypic-microbiome integrated monitoring could serve as a candidate modality to obtain metrics for therapeutic efficacy and adjust treatment strategy as similar therapies progress from laboratory measures to bedside care [197]. A machine learning model trained on electronic health records (EHRs) from a large, multicenter cohort has demonstrated its ability to predict clinically meaningful wound healing trajectories within the early weeks of treatment across a large, multi-institutional population. This predictive capacity enables decision support for the tailoring and escalation of personalized therapeutic strategies, and highlights the value as well as the importance of clinical-engineering collaboration [198]. In brief, Fig. 5 schematically summarizes the main barriers and emerging technological solutions in inflammation-modulated wound healing, in addition to illustrating how converging innovations can be integrated through multidisciplinary team science across different translational stages. Fig. 5Challenges and opportunities in the clinical translation of inflammation-modulated wound healing. This schematic summarizes challenges and opportunities in the clinical translation of inflammation-modulated wound healing. Supplementary data (A) Wound heterogeneity, microbial biofilms, cross-species differences, and limitations in clinical trial design and implementation represent major barriers. (B) These advanced technologies include microneedles, exosome-based hydrogels, stimuli-responsive biomaterials, and smart consumables with potential applications in targeted and regenerative therapeutics. (C) Shaping the future-integrating multi-omics profiling, clinical teams, molecular diagnostics, and data-driven approaches facilitates precision-guided interventions and improves translational efficiency Challenges and opportunities in the clinical translation of inflammation-modulated wound healing. This schematic summarizes challenges and opportunities in the clinical translation of inflammation-modulated wound healing. Supplementary data (A) Wound heterogeneity, microbial biofilms, cross-species differences, and limitations in clinical trial design and implementation represent major barriers. (B) These advanced technologies include microneedles, exosome-based hydrogels, stimuli-responsive biomaterials, and smart consumables with potential applications in targeted and regenerative therapeutics. (C) Shaping the future-integrating multi-omics profiling, clinical teams, molecular diagnostics, and data-driven approaches facilitates precision-guided interventions and improves translational efficiency Discussion Inflammation plays a double-edged role in wound healing. Moderate activation contributes to clearance of necrotic tissue, protection against infection, and induction of repair; however, overactivation or prolonged inflammation destroys the balance of the local environment, leading to deterioration of healing and fibrosis or even chronic nonhealing wounds. Clinically, this underscores the importance of achieving a proper ‘defense’ and ‘repair’ balance strong enough to mount sufficient, normal immune activation while avoiding excessive inflammation. This balance is inherently a dose-response issue, whereby insufficient and excessive anti-inflammatory intervention both contribute to suboptimal healing outcomes. Basic research has revealed that immune cell phenotype switching, cytokine regulation, and temporally coordinated signaling pathways are critical during the healing process [199], providing a theoretical foundation for subsequent interventions. This framework should also incorporate neuro-immune crosstalk, as injury-sensing neurons and immune cells jointly determine the timing and magnitude of early repair initiation. This interaction may represent an early regulatory checkpoint that determines the timing and magnitude of inflammatory activation and subsequent repair progression. At the therapeutic level, traditional drugs, physical intervention systems and local care may be beneficial for repair; however, they somewhat lack the ability to moderately adjust the intensity and duration of inflammation. Novel strategies including functional hydrogels [200], exosome-based carriers [201], and microneedle delivery systems have emerged as targeted drug or biological signaling release systems that can achieve anti-inflammatory and pro-repair activities. At the same time, immunomodulation at both cellular and molecular levels such as treatments targeted on regulatory T cells, miRNAs and growth factor signaling pathways has shown possibilities to stimulate angiogenesis, collagen generation and even decrease scar formation [202, 203]. These advances not only expand therapeutic strategies but also underscore the value of interdisciplinary integration in the management of refractory wounds. The process of wound healing has a significant amount of inter-individual variability. The wound microenvironment, shaped by host genetic background, metabolic status, and microbial factors, contributes to significant heterogeneity of inflammatory responses between patients. Over the past few years, multi-omics technologies and computational learning-guided surveillance have enabled the identification of subtypes of inflammation, prediction of healing course, and design of individualized interventions [197, 204]. Nonetheless, the clinical application of these devices is currently hampered by important barriers that include limited standardization and insufficient evidence strength. Future research should be based on large-scale, multicenter clinical trials to build a uniformly standardized outcome evaluation system, making strides toward bidirectional correlation of basic research and clinical practice, allowing the control of inflammatory response and wound healing to become more precise. Thus, modulating inflammation is key for proper wound healing. An improved understanding of the interplay between inflammation and regeneration, rational design of combination therapies targeting anti-inflammatory approaches along with pro-repair mechanisms, as well as personalized therapy, will ensure better healing outcomes, thus avoiding complications, and may also help achieve faster clinical translation.